Emerald Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-212,358
| Closed | -$4.88M | – | 257 |
|
|
2025
Q4 | $4.88M | Sell |
212,358
-206,208
| -49% | -$6.78M | 0.15% | 114 |
|
|
2025
Q3 | $12.6M | Sell |
418,566
-42,836
| -9% | -$1.28M | 0.4% | 94 |
|
|
2025
Q2 | $16.8M | Sell |
461,402
-54,826
| -11% | -$1.98M | 0.61% | 66 |
|
|
2025
Q1 | $18.7M | Sell |
516,228
-2,100
| -0.4% | -$87.4K | 0.84% | 45 |
|
|
2024
Q4 | $21.8M | Sell |
518,328
-51,470
| -9% | -$2.55M | 0.84% | 48 |
|
|
2024
Q3 | $31.7M | Buy |
569,798
+83,116
| +17% | +$4.23M | 1.22% | 26 |
|
|
2024
Q2 | $20M | Sell |
486,682
-1,456
| -0.3% | -$62.2K | 0.84% | 47 |
|
|
2024
Q1 | $22.8M | Buy |
488,138
+6,000
| +1% | +$283K | 0.92% | 41 |
|
|
2023
Q4 | $23.1M | Sell |
482,138
-9,551
| -2% | -$370K | 0.99% | 37 |
|
|
2023
Q3 | $17.5M | Sell |
491,689
-60,447
| -11% | -$2.39M | 0.85% | 48 |
|
|
2023
Q2 | $25.5M | Buy |
552,136
+61,975
| +13% | +$2.87M | 1.11% | 29 |
|
|
2023
Q1 | $19.7M | Buy |
490,161
+145,436
| +42% | +$6.24M | 0.94% | 41 |
|
|
2022
Q4 | $16M | Sell |
344,725
-2,356
| -0.7% | -$92.7K | 0.77% | 61 |
|
|
2022
Q3 | $14.4M | Buy |
347,081
+145,864
| +72% | +$7.5M | 0.74% | 58 |
|
|
2022
Q2 | $12M | Sell |
201,217
-22,735
| -10% | -$1.4M | 0.62% | 70 |
|
|
2022
Q1 | $16.3M | Sell |
223,952
-11,793
| -5% | -$821K | 0.62% | 68 |
|
|
2021
Q4 | $19.8M | Buy |
235,745
+39,621
| +20% | +$3.22M | 0.73% | 60 |
|
|
2021
Q3 | $17.7M | Sell |
196,124
-14,119
| -7% | -$1.28M | 0.64% | 67 |
|
|
2021
Q2 | $20M | Sell |
210,243
-18,125
| -8% | -$1.89M | 0.73% | 54 |
|
|
2021
Q1 | $26M | Buy |
228,368
+1,493
| +0.7% | +$203K | 0.94% | 33 |
|
|
2020
Q4 | $31.4M | Buy |
+226,875
| New | +$26.9M | 1.04% | 30 |
|
|
2017
Q1 | – | Sell |
-337,629
| Closed | -$23.7M | – | 262 |
|
|
2016
Q4 | $23.7M | Buy |
337,629
+67,646
| +25% | +$4.8M | 1.01% | 35 |
|
|
2016
Q3 | $19.2M | Buy |
+269,983
| New | +$17.2M | 0.85% | 30 |
|
|
2015
Q3 | – | Sell |
-69,590
| Closed | -$7.13M | – | 347 |
|
|
2015
Q2 | $7.13M | Sell |
69,590
-1,111
| -2% | -$86.3K | 0.34% | 99 |
|
|
2015
Q1 | $4.21M | Sell |
70,701
-46,480
| -40% | -$2.58M | 0.21% | 141 |
|
|
2014
Q4 | $5.14M | Buy |
117,181
+74,480
| +174% | +$3.41M | 0.27% | 119 |
|
|
2014
Q3 | $2.42M | Buy |
42,701
+3,991
| +10% | +$201K | 0.14% | 190 |
|
|
2014
Q2 | $1.74M | Buy |
38,710
+12,040
| +45% | +$496K | 0.1% | 214 |
|
|
2014
Q1 | $1.3M | Buy |
+26,670
| New | +$1.37M | 0.07% | 234 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG